{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:40:03Z","timestamp":1792741203429,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/igo\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.vaccine.2022.02.003","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T07:48:22Z","timestamp":1645084102000},"page":"1707-1711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["The efficacy and safety of rotavirus vaccines in countries in Africa and Asia with high child mortality"],"prefix":"10.1016","volume":"40","author":[{"given":"N.","family":"Henschke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hungerford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.A.","family":"Cunliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.F.","family":"Grais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.D.","family":"Parashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"Neuzil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.02.003_b0005","unstructured":"Organization WH. List of Prequalified Vaccines; 2021 [Available from: https:\/\/extranet.who.int\/pqweb\/vaccines\/list-prequalified-vaccines."},{"key":"10.1016\/j.vaccine.2022.02.003_b0010","doi-asserted-by":"crossref","unstructured":"Tate JE, Burton AH, Boschi-Pinto C, Parashar UD, Network WHOCGRS, Agocs M, et al. Global, regional, and national estimates of rotavirus mortality in children < 5 years of age, 2000\u20132013. Clinical Infectious Diseases 2016;62(suppl_2):S96-S105.","DOI":"10.1093\/cid\/civ1013"},{"issue":"9","key":"10.1016\/j.vaccine.2022.02.003_b0015","doi-asserted-by":"crossref","first-page":"e1195","DOI":"10.1016\/S2214-109X(20)30262-X","article-title":"Real-world effectiveness of rotavirus vaccines, 2006\u201319: a literature review and meta-analysis","volume":"8","author":"Burnett","year":"2020","journal-title":"Lancet Global Health"},{"issue":"1","key":"10.1016\/j.vaccine.2022.02.003_b0020","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-017-2613-4","article-title":"Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies","volume":"17","author":"Hungerford","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2022.02.003_b0025","unstructured":"World Health Organization = Organisation mondiale de la S. Weekly Epidemiological Record, 2020, vol. 95, 48 [full issue]. Weekly Epidemiological Record = Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire. 2020;95(48):585-608."},{"issue":"11","key":"10.1016\/j.vaccine.2022.02.003_b0030","doi-asserted-by":"crossref","first-page":"e1541","DOI":"10.1016\/S2214-109X(19)30412-7","article-title":"Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules","volume":"7","author":"Clark","year":"2019","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.vaccine.2022.02.003_b0035","article-title":"Vaccines for preventing rotavirus diarrhoea: vaccines in use","volume":"11","author":"Bergman","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2022.02.003_b0040","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.83","article-title":"Rotavirus infection","volume":"3","author":"Crawford","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.vaccine.2022.02.003_b0045","unstructured":"Organization WH. Strategic Advisory Group of Experts on Immunization (SAGE) - October 2020; 2020 [Available from: https:\/\/www.who.int\/news-room\/events\/detail\/2020\/10\/05\/default-calendar\/sage_meeting_october_2020."},{"key":"10.1016\/j.vaccine.2022.02.003_b0050","unstructured":"IGME) UNI-aGfCMEU. Levels & Trends in Child Mortality: Report 2019, Estimates developed by the United Nations Inter-agency Group for Child Mortality Estimation. New York; 2019."},{"issue":"1","key":"10.1016\/j.vaccine.2022.02.003_b0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/14740338.2019.1561857","article-title":"Approaches to monitoring intussusception following rotavirus vaccination","volume":"18","author":"Tate","year":"2019","journal-title":"Expert Opinion Drug Safety"},{"issue":"9741","key":"10.1016\/j.vaccine.2022.02.003_b0060","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Armah","year":"2010","journal-title":"The Lancet"},{"issue":"9741","key":"10.1016\/j.vaccine.2022.02.003_b0065","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Zaman","year":"2010","journal-title":"The Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2022.02.003_b0070","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/cid\/ciw346","article-title":"Delayed dosing of oral rotavirus vaccine demonstrates decreased risk of rotavirus gastroenteritis associated with serum zinc: a randomized controlled trial","volume":"63","author":"Colgate","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2022.02.003_b0075","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMoa0904797","article-title":"Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants","volume":"362","author":"Madhi","year":"2010","journal-title":"N Engl J Med"},{"issue":"S1","key":"10.1016\/j.vaccine.2022.02.003_b0080","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1086\/653550","article-title":"Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants","volume":"202","author":"Steele","year":"2010","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2022.02.003_b0085","doi-asserted-by":"crossref","first-page":"e1002282","DOI":"10.1371\/journal.pmed.1002282","article-title":"Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial","volume":"14","author":"Zaman","year":"2017","journal-title":"PLoS Med"},{"issue":"9935","key":"10.1016\/j.vaccine.2022.02.003_b0090","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/S0140-6736(13)62630-6","article-title":"Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial","volume":"383","author":"Bhandari","year":"2014","journal-title":"The Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2022.02.003_b0095","doi-asserted-by":"crossref","first-page":"e1003655","DOI":"10.1371\/journal.pmed.1003655","article-title":"Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial","volume":"18","author":"Isanaka","year":"2021","journal-title":"PLoS Med"},{"issue":"45","key":"10.1016\/j.vaccine.2022.02.003_b0100","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1016\/j.vaccine.2017.09.014","article-title":"A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants","volume":"35","author":"Kulkarni","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.02.003_b0105","doi-asserted-by":"crossref","first-page":"A52","DOI":"10.1016\/j.vaccine.2011.08.043","article-title":"Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya","volume":"30","author":"Feikin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.02.003_b0110","doi-asserted-by":"crossref","first-page":"A71","DOI":"10.1016\/j.vaccine.2011.11.094","article-title":"Efficacy of the oral pentavalent rotavirus vaccine in Mali","volume":"30","author":"Sow","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.02.003_b0115","doi-asserted-by":"crossref","first-page":"A79","DOI":"10.1016\/j.vaccine.2012.01.022","article-title":"Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa","volume":"30","author":"Tapia","year":"2012","journal-title":"Vaccine"},{"issue":"39","key":"10.1016\/j.vaccine.2022.02.003_b0120","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1016\/j.vaccine.2008.08.034","article-title":"Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines","volume":"28","author":"Steele","year":"2010","journal-title":"Vaccine"},{"issue":"31-32","key":"10.1016\/j.vaccine.2022.02.003_b0125","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1016\/j.vaccine.2006.05.001","article-title":"Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial","volume":"24","author":"Bhandari","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.02.003_b0130","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/600104","article-title":"A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial","volume":"200","author":"Bhandari","year":"2009","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2022.02.003_b0135","doi-asserted-by":"crossref","first-page":"e00302","DOI":"10.1016\/j.heliyon.2017.e00302","article-title":"ROTAVAC\u00ae does not interfere with the immune response to childhood vaccines in Indian infants: A randomized placebo controlled trial","volume":"3","author":"Chandola","year":"2017","journal-title":"Heliyon"},{"issue":"33","key":"10.1016\/j.vaccine.2022.02.003_b0140","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/j.vaccine.2020.05.093","article-title":"Assessment of risk of intussusception after pilot rollout of rotavirus vaccine in the Indian public health system","volume":"38","author":"Bhandari","year":"2020","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2022.02.003_b0145","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/cid\/ciz431","article-title":"Evaluation of intussusception after oral monovalent rotavirus vaccination in South Africa","volume":"70","author":"Groome","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"20","key":"10.1016\/j.vaccine.2022.02.003_b0150","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMoa2002276","article-title":"Intussusception after rotavirus vaccine introduction in India","volume":"383","author":"Reddy","year":"2020","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.vaccine.2022.02.003_b0155","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa1713909","article-title":"Evaluation of intussusception after monovalent rotavirus vaccination in Africa","volume":"378","author":"Tate","year":"2018","journal-title":"N Engl J Med"},{"issue":"505","key":"10.1016\/j.vaccine.2022.02.003_b0160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav6419","article-title":"Evaluating strategies to improve rotavirus vaccine impact during the second year of life in Malawi","volume":"11","author":"Pitzer","year":"2019","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.vaccine.2022.02.003_b0165","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.vaccine.2015.11.065","article-title":"The 5As: A practical taxonomy for the determinants of vaccine uptake","volume":"34","author":"Thomson","year":"2016","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22001256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22001256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:10:35Z","timestamp":1759403435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22001256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0264410X22001256"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.02.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of rotavirus vaccines in countries in Africa and Asia with high child mortality","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}